Abstract
The effect of prolonged treatment with amitriptyline on the secretory activity of rat salivary glands evoked by parasympathetic nerve stimulation and isoprenaline administration has been studied. Low doses of amitriptyline (10 mg/kg per day for 2 or 4 weeks), did not significantly affect salivary flow evoked by either parasympathetic nerve or isoprenaline stimulation. Higher doses of amitriptyline (50 mg/kg/day for 2 or 4 weeks) however, markedly decreased parasympathetic-evoked salivary secretion (flow and volume) from both parotid and submandibular glands, while isoprenaline-evoked secretions were unaffected. Sodium, potassium, and calcium concentrations of nerve-elicited or isoprenaline-evoked saliva were not significantly altered by amitriptyline treatment. Protein concentration and amylase activity of nerve-elicited parotid saliva were, however, greatly increased by chronic amitriptyline administration. Possible mechanisms for drug-induced increase in nerveelicited salivary protein concentration include changes in cholinergic receptor binding, release of neuropeptides and variations in phosphatidylinositol turnover, which need further study.
Similar content being viewed by others
References
Bertram U, Kragh-Sörensen P, Rafaelsen OJ, Larsen NE. Saliva secretion following long-term antidepressant treatment with nortriptyline controlled by plasma levels.Scand J Dent Res 1979;87: 58–64.
Clemmesen L, Mikkelsen PL, Lund H, Bolwig TG, Rafaelsen OJ. Assessment of the anticholinergic effects of antidepressants in a single dose cross-over study of salivation and plasma levels.Psychopharmacology 1984;82: 348–354.
Rundegren J, Van Dijken J, Mörnstad H, von Knorring L. Oral conditions in patients receiving long-term treatment with cyclic antidepressant drugs.Swed Dent J 1985;9: 55–64.
Yu JH, Chen YY, Suarez K. Acute amitriptyline effects on parasympathetic-evoked rat saliva.Neuropsychobiology 1989;20: 132–135.
Johnson DA. Regulation of salivary glands and their secretions by masticatory, nutritional and hormonal factors. In: Sreebny LM, ed.The Salivary System. Boca Raton, FL: CRC Press, 1987; 135–155.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent.J Biol Chem 1951;193: 265–275.
Myers VC, Free AH, Rosinski EE. Studies of animal diastases. VI. The determination of diastase (amylase) in blood.Biol Chem 1944;154: 39–48.
von Knorring L, Mörnstad H. Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission.Neuropsychobiology 1986;15: 146–154.
Maitre L, Moser P, Bauman PA, Waldmeier PC. Amine uptake inhibitors: criteria of selectivity.Acta Psychiat Scand 1980;61 (suppl 280): 97–220.
Hughes IE. The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves.Br J Pharmac 1978;63: 315–321.
Wallace D, Schramm M. Calcium and the exportable protein in rat parotid gland parallel subcellular distribution and concomitant secretion.Eur J Biochem 1971;21: 433–437.
Ekström J. Neuropeptides and secretion.J Dent Res 1987;66: 524–530.
Hirasawa K, Nishizuka Y. Phosphatidylinositol turnover in receptor mechanism and signal transduction.Ann Rev Pharmacol Toxicol 1985;25: 147–170.
Hokin LE. Receptors and phosphoinositide-generated second messengers.Ann Rev Biochem 1985;54: 205–235.
Downes CP. Agonist-stimulated phosphatidylinositol 4,5-biphosphate metabolism in the nervous system.Neurochem Int 1986;9: 211–230.
Berridge MJ. Cell signalling through phospholipid metabolism.J Cell Sci 1986; (suppl)4: 137–153.
Oborne NN. Tricyclic antidepressants, mianserin, and ouabain stimulate inositol phosphate formationin vitro in rat cortical slice.Neurochem Res 1988;13: 105–111.
Sreebny LM, Broich G. Xerostomia (dry mouth). In: Sreebny LM, ed.The Salivary System. Boca Raton, FL: CRC Press, 1988; 179–202.
Baum BJ, Bodner L, Fox PC, Izutsu KT, Pizzo PA, Wright WE. Therapy-induced dysfunction of salivary glands: implications for oral health.Special Care in Dentistry 1985;5(6): 274–277.
Henkin RI, Talol N, Larson AL, Mattern C, Abnormalities of taste and smell in Sjogren's syndrome.Ann Intern Med 1972;76: 375.
Slome BA. Rampant caries: a side effect of tricyclic antidepressant therapy.Gen Dent 1984;32(6: 494–496.
Spielman A, Ben-Aryeh H, Gutman D, Szargel R, Deutsch E. Xerostomia—diagnosis and treatment.Oral Surg 1981;51: 144–147.
Navazesh A. Xerostomia in the aged.Dent Clin North America 1989;33: 75–80.
Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance.J Am Dent Assoc 1987;115: 581–584.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yu, JH. Effects of chronic amitriptyline administration on saliva from the parotid and submandibular glands of the rat. Clinical Autonomic Research 2, 5–15 (1992). https://doi.org/10.1007/BF01824205
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01824205